| Miss Margaret Parsons, | |
|
2431 Mariner Square Dr, Alameda, CA 94501-1684 | |
| (510) 296-5377 | |
| Not Available |
| Full Name | Miss Margaret Parsons |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2431 Mariner Square Dr, Alameda, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164299673 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 19802 (California) | Primary |
| Provider Name | Orthopaedic And Neurological Rehab Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1225496540 PECOS PAC ID: 6507159126 Enrollment ID: O20160720000431 |
News Archive
Researchers at the Stanford University School of Medicine have identified a set of molecular brakes that stabilize the developing brain's circuitry. Moreover, experimentally removing those brakes in mice enhanced the animals' performance in a test of visual learning, suggesting a long-term path to therapeutic application.
Osiris Therapeutics, Inc. announced today that it has entered into an agreement with a wholly-owned subsidiary of Mesoblast Limited for the sale of Osiris' culture-expanded mesenchymal stem cell business, including Prochymal, in a transaction worth up to $100 million in initial consideration and milestone payments.
New research reveals bias and stereotyping among clinical and research professionals who recruit patients to enroll in cancer clinical trials.
The National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH) announced a pilot program under which "three pharmaceutical companies have agreed to make dozens of their failed compounds available to researchers, who will investigate if the compounds can be re-purposed into successful treatments for other diseases," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC), writes in the group's "Breakthroughs" blog.
NPR's "Shots" blog reports on one of the drug trials considered by the FDA in its approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to prevent HIV among people at risk of contracting the virus, which "was done at the Oswaldo Cruz Foundation Research Institute, also known as Fiocruz, in Rio de Janeiro."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Margaret Parsons, 1960 N Main St Unit 126, Walnut Creek, CA 94596-3928 Ph: (916) 607-4401 | Miss Margaret Parsons, 2431 Mariner Square Dr, Alameda, CA 94501-1684 Ph: (510) 296-5377 |
News Archive
Researchers at the Stanford University School of Medicine have identified a set of molecular brakes that stabilize the developing brain's circuitry. Moreover, experimentally removing those brakes in mice enhanced the animals' performance in a test of visual learning, suggesting a long-term path to therapeutic application.
Osiris Therapeutics, Inc. announced today that it has entered into an agreement with a wholly-owned subsidiary of Mesoblast Limited for the sale of Osiris' culture-expanded mesenchymal stem cell business, including Prochymal, in a transaction worth up to $100 million in initial consideration and milestone payments.
New research reveals bias and stereotyping among clinical and research professionals who recruit patients to enroll in cancer clinical trials.
The National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH) announced a pilot program under which "three pharmaceutical companies have agreed to make dozens of their failed compounds available to researchers, who will investigate if the compounds can be re-purposed into successful treatments for other diseases," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC), writes in the group's "Breakthroughs" blog.
NPR's "Shots" blog reports on one of the drug trials considered by the FDA in its approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to prevent HIV among people at risk of contracting the virus, which "was done at the Oswaldo Cruz Foundation Research Institute, also known as Fiocruz, in Rio de Janeiro."
› Verified 8 days ago
Mr. Edward De Guzman Domantay, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1114 Willow St, B, Alameda, CA 94501 Phone: 510-864-0763 | |
Ms. Karen Wilhoite, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 140 Nottingham Dr, Alameda, CA 94502 Phone: 510-523-1543 | |
Ms. Margaret Mary Duggan Maceda, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1717 Minturn St, Alameda, CA 94501 Phone: 510-220-2077 Fax: 510-248-4010 | |
Miss Anadee Nikte, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 430 Willow St, Alameda, CA 94501 Phone: 510-523-8857 | |
Ms. Brianne Frey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 516 Willow St, Alameda, CA 94501 Phone: 530-570-5177 | |
Claire Bonde, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3247 Sterling Ave, Alameda, CA 94501 Phone: 510-995-8873 |